< Back to previous page
Researcher
Ruben Faelens
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Drug Delivery and Disposition (Division)
Member
From7 Nov 2017 → 12 Sep 2022
Projects
1 - 1 of 1
- Computer-assisted dosing recommendation framework, feasibility study and proof of concept implementation for tacrolimusFrom1 Nov 2017 → 7 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 8 of 8
- Computer-assisted dosing recommendation framework, feasibility study and proof of concept implementation for tacrolimus(2022)
Authors: Ruben Faelens, Pieter Annaert, Dirk Kuypers
- Erdafitinib's effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer(2022)
Authors: Ruben Faelens
Pages: 569 - 580 - Predicting model-informed precision dosing: A test-case in tacrolimus dose adaptation for kidney transplant recipients(2022)
Authors: Ruben Faelens, Dirk Kuypers, Pieter Annaert
Pages: 348 - 361 - Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis(2021)
Authors: Ruben Faelens, Zhigang Wang, Paul Declerck, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
- Glomerular Filtration Rate in Asphyxiated Neonates Under Therapeutic Whole-Body Hypothermia, Quantified by Mannitol Clearance(2021)
Authors: Neel Deferm, Ruben Faelens, Anne Smits, Pieter Annaert, Karel Allegaert
Pages: 897 - 906 - Spatiotemporal imaging and pharmacokinetics of fluorescent compounds in zebrafish eleuthero-embryos after different routes of administration(2021)
Authors: Marlly Guarin, Ruben Faelens, Deirdre Cabooter, Pieter Annaert, Peter de Witte, Annelii Ny
- Optimising infliximab induction dosing for patients with ulcerative colitis(2019)
Authors: Erwin Dreesen, Ruben Faelens, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils, Thomas Bouillon
Pages: 782 - 795 - ADAPTIVE DOSING DURING INFLIXIMAB INDUCTION THERAPY CAN IMPROVE MUCOSAL HEALING RATES IN PATIENTS WITH ULCERATIVE COLITIS(2018)
Authors: Erwin Dreesen, Ruben Faelens, Gert A Van Assche, Marc Ferrante, Severine Vermeire, Ann Gils, Thomas Bouillon
Pages: S823 - S823